Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Feb;44(2):400-4.
doi: 10.1128/AAC.44.2.400-404.2000.

Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose

Affiliations

Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose

J L Rodríguez-Tudela et al. Antimicrob Agents Chemother. 2000 Feb.

Abstract

Cryptococcus neoformans is a nonfermentative yeast that requires oxygen for growth. The shaking of culture media achieves good oxygenation, promoting the growth of cryptococci. In this study, three test media (RPMI 1640, RPMI 1640-2% glucose, and buffered yeast nitrogen base ¿BYNB) recommended in the National Committee for Clinical Laboratory Standards M27A standard were examined. Growth abilities and minimum inhibitory concentrations (MICs) in microplates incubated at 35 degrees C for 48 h were determined. The results indicated that shaking and an inoculum size of 10(5) CFU/ml yielded optimal growth of this yeast. Compared to RPMI 1640, supplementation of RPMI 1640 with 2% glucose did not significantly improve growth of C. neoformans and resulted in an 8.7-h delay of exponential growth. Cryptococcal growth in RPMI 1640 at 24 h was notably better than that in RPMI-2% glucose, although by 48 h the growths were comparable. The MIC range of amphotericin B observed for the C. neoformans strains grown in RPMI 1640 with or without glucose was too narrow to allow the separation of susceptible and resistant strains based on clinical outcome. The widest ranges of MICs of flucytosine and fluconazole were obtained with BYNB. This work demonstrates the need for a new antifungal susceptibility test for C. neoformans.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Mean growth curve of 16 C. neoformans isolates incubated at 35°C in static or shaken culture media at 1,400 rpm.
FIG. 2
FIG. 2
Mean curve of seven inhibition curves of C. neoformans ATCC 90112 produced by amphotericin B, flucytosine, fluconazole, and itraconazole in static and 350-rpm-agitated microplates incubated for 48 h at 35°C.

References

    1. Ghannoum M A, Ibrahim A S, Fu Y, Shafiq M C, Edwards J E, Jr, Criddle R S. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol. 1992;30:2881–2886. - PMC - PubMed
    1. Larsen R A, Bozzette S A, Jones B E, Haghighat D, Leal M A, Forthal D, Bauer M, Tilles J G, McCutchan J A, Leedom J M. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis. 1994;19:741–745. - PubMed
    1. Lozano-Chiu M, Paetznick V L, Ghannoum M A, Rex J H. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J Clin Microbiol. 1998;36:2817–2822. - PMC - PubMed
    1. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. 1997. Approved standard. National Committee for Clinical Laboratory Standards, Wayne, Pa.
    1. Odds F C, De Backer T, Dams G, Vranckx L, Woestenborghs F. Oxygen as limiting nutrient for growth of Cryptococcus neoformans. J Clin Microbiol. 1995;33:995–997. - PMC - PubMed

MeSH terms